DexCom, Inc. (NASDAQ:DXCM) announced that Brice Bobzien, Senior Vice President of Finance, will present an update at the Piper Sandler Ophthalmology and Diabetes Symposium on May 25, 2022, at 1:00 p.m. EDT. The presentation will be accessible via webcast on the Dexcom Investor Relations website, where it will also be archived for future viewing.
Headquartered in San Diego, California, DexCom leads in diabetes care technology through innovative continuous glucose monitoring products.
Positive
None.
Negative
None.
Insights
Analyzing...
SAN DIEGO--(BUSINESS WIRE)--
DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on Wednesday, May 25, 2022 at 1:00 p.m. (EDT).
Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.